New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
08:58 EDTCOCO, DATA, XONE, DDD, CTSH, VJET, SSYS, OMER, MRK, RLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Merck (MRK), up 1.6%... Ralph Lauren (RL), up 7%... Tableau Software (DATA), up 12%... Corinthian Colleges (COCO), up 2%. ALSO HIGHER: Omeros (OMER), up 11% after granted fast track designation to OMS824 by FDA. DOWN AFTER EARNINGS: Allergan (AGN), down xx%... Cognizant (CTSH), down 5%. ALSO LOWER: 3D Systems (DDD), down 15% after lowering FY13 EPS view, guiding FY14 below estimates. Peers Stratasys (SSYS), down 7.5%, ExOne (XONE), down 8%, and Voxeljet (VJET), down 7%, lower as well.
News For DDD;RL;SSYS;XONE;MRK;VJET;DATA;OMER;CTSH;COCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 27, 2015
05:02 EDTDDD3D Systems downgraded to Hold from Buy at Jefferies
Subscribe for More Information
January 26, 2015
08:31 EDTMRKMerck says CHMP issues positive opinion for Sivextro
Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of the investigational antibiotic SIVEXTRO for the treatment of acute bacterial skin and skin structure infections in adults. Merck acquired SIVEXTRO as a part of its purchase, through a subsidiary, of Cubist Pharmaceuticals, Inc. The CHMP positive opinion will be reviewed by the European Commission. If the European Commission affirms the CHMP opinion, it will grant a centralized marketing authorization with unified labeling that is valid in the 28 countries that are members of the European Union, as well as European Economic Area members, Iceland, Liechtenstein and Norway. SIVEXTRO is a once-daily oxazolidinone antibiotic developed for both intravenous and oral administration for the treatment of serious infections caused by certain Gram-positive bacteria.
January 23, 2015
10:02 EDTDATAOn the Fly: Analyst Initiation Summary
Subscribe for More Information
07:39 EDTCTSHCognizant reinstated with an Outperform at Credit Suisse
Subscribe for More Information
06:39 EDTMRKNIH, GlaxoSmithKline, Merck launch joint Ebola vaccine test in Liberia, WSJ says
Subscribe for More Information
January 22, 2015
16:27 EDTDATATableau initiated with a Market Perform at Cowen
Subscribe for More Information
08:20 EDTDDD3D Systems February volatility at low end of historic range
3D Systems February call option implied volatility is at 40, March is at 46; compared to its 26-week average of 47 according to Track Data. Low February option implied volatility suggests decreasing price movement into the expected release of Q4 results in late February.
January 21, 2015
10:16 EDTMRKLeerink biopharma analysts hold an analyst/industry conference call
Analyst Fernandez, along with Dr. Paul Gurbel and Dr. Richard Becker, discuss AstraZeneca's PEGASUS trial and the current use of Brilinta and dual antiplatelet therapy for prevention of CV disease and implications of the recently completed DAPT trial on an Analyst/Industry conference call to be held on January 21 at 1:30 pm.
08:02 EDTMRKMerck completes tender offer to acquire Cubist
Merck (MRK) announced the successful completion of the tender offer for all of the outstanding shares of common stock of Cubist Pharmaceuticals (CBST) at a purchase price of $102.00 per share. As of the tender offer expiration yesterday, 58,039,667 shares of common stock of Cubist were validly tendered and not properly withdrawn from the tender offer, representing approximately 75.7% of the outstanding common stock of Cubist on a fully diluted basis. All of such shares have been accepted for payment in accordance with the terms of the tender offer, and Merck expects to promptly pay for all such shares. Following consummation of the tender offer, Merck expects to complete the acquisition of Cubist later today through a merger of Merckís wholly owned subsidiary with and into Cubist without stockholder approval. Upon completion of the merger, all outstanding shares of common stock of Cubist, other than shares held by Cubist in treasury or shares held by Cubistís stockholders who are entitled to and properly exercise appraisal rights under Delaware law, will be canceled and converted into the right to receive cash equal to the $102.00 offer price per share without interest, less any applicable withholding taxes. In addition, upon completion of the merger, Cubist will become a wholly owned subsidiary of Merck and the common stock of Cubist will cease to be traded on the NASDAQ Stock Market.
07:53 EDTVJETvoxeljet sentiment can shift if company executes, says Brean Capital
Subscribe for More Information
07:09 EDTDDD, SSYSPiper positive on Stratasys, cautious on 3D Systems after survey
Subscribe for More Information
January 20, 2015
17:18 EDTMRKDana Holding to replace Cubist in S&P 400 as of 1/22 close
Subscribe for More Information
12:22 EDTVJETvoxeljet 2015 guidance 'encouraging,' says Piper Jaffray
Subscribe for More Information
10:15 EDTDDD3D Systems call activity attributed to takeover speculation
3D Systems January weekly 29 and 30 calls are active on total call volume of 8,600 contracts (900 puts) on renewed takeover speculation. January weekly call option implied volatility is at 78, February is at 53, March is at 56; compared to its 26-week average of 47 according to Track Data. Active call volume suggests traders taking positions for price movement.
10:07 EDTDDDRumor: 3D Systems strength attributed to takeover speculation
Shares of 3D Systems are moving higher on speculation the company has hired an investment bank to review a potential sale of the company.
08:46 EDTVJETvoxeljet sees long-term revenue growth rate in the range of 50%
Subscribe for More Information
08:45 EDTVJETvoxeljet sees FY15 revenue kEUR23,000-kEUR24,000
Subscribe for More Information
07:23 EDTMRKMerck funding testing of lower dosages of Zilmax, Reuters reports
Subscribe for More Information
January 16, 2015
17:11 EDTOMEROmeros files automatic mixed securities shelf
Subscribe for More Information
17:05 EDTOMEROmeros requests withdrawal of registration statement
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use